OBSERVE MEDICAL ASA: Mandatory notification of trade grant of share options - correction
Observe Medical ASA (OBSRV) · publisert 9. april 2026 kl. 17:02 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Jørgen Mann | CEO | Annet Tildeling | 250 000 | 0 NOK | 9. april 2026 | NO0010865009 | XOFF |
Vedlegg
- OMASA_Share_Options_PDMR_090426.pdf (application/pdf, originaldokument)
Meldingstekst
Reference is made to the stock exchange announcement published by Observe
Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 9 April
2026 regarding the grant of share options to primary insider and CEO Jørgen
Mann.
The announcement did not include the mandatory notification form. The
notification form is attached to this announcement.
This information is subject to disclosure requirements pursuant to Article 19 of
Regulation EU 596/2014 (the EU Market Abuse Regulation) and Section 5-12 of the
Norwegian Securities Trading Act.